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We are entering an era of epigenome engineering.
The precision manipulation of chromatin and
epigenetic modifications provides new ways to
interrogate their influence on genome and cell
function and to harness these changes for applications.
We review the design and state of epigenome editing
tools, highlighting the unique regulatory properties
afforded by these systems.advances, many questions remain unresolved, especiallyIntroduction
Chromatin is decorated by a large array of biochemical
modifications made to DNA and histone proteins [1].
These modifications—and the broader organizational
structure of chromatin—provide an important additional
layer of information that is superimposed upon genome
sequence and thus are widely referred to as the epige-
nome. Given its physical association with genomic
material, the epigenome has been suggested to play key
roles in regulating genome structure and function,
including the timing, strength, and memory of gene ex-
pression [2–4]. The epigenome is thought to help con-
trol which genes are expressed in a given context, for
example, to produce the gene expression patterns that
underlie the many different cellular phenotypes that
arise during an organism’s development. Because many
modifications are heritably maintained, the epigenome is
also believed to be key in determining how these gene
expression patterns are subsequently maintained for the
life of an organism. Moreover, a large body of evidence
suggests that the epigenome is inappropriately altered in
many human diseases, including most cancers [5–8].* Correspondence: akhalil@bu.edu
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about the function of the epigenome. Recently, with the
advent of genomic techniques, there has been remark-
able progress in our ability to map epigenomic modifica-
tions at a global scale and to correlate them with gene
expression. While the roles of many chromatin modifica-
tions remain unclear, some important patterns have
begun to emerge in which epigenome states have come
to define key signatures of gene regulation, cell activity,
and even disease states [2, 3]. Despite these significant
concerning the cause and consequence of chromatin
marks with respect to gene expression and other regula-
tory processes. Thus, the stage is set for the develop-
ment of new methods that can selectively manipulate
and probe the epigenome. Tools that can be used to edit
chromatin modifications at specific locations and times
will deepen our functional understanding of the epige-
nome, for example, by allowing researchers to directly
interrogate the relationship between the epigenome and
transcriptional control. They will also provide opportun-
ities to transform the increasingly precise genome-wide
maps that have been generated for developmental and
disease states into therapeutics and other benefits for
human health.
At the center of these new efforts are the
programmable DNA-targeting technologies behind the
genome engineering revolution: zinc fingers (ZFs),
transcription activator-like effectors (TALEs), and the
CRISPR/Cas systems. These technologies are now
being utilized for targeted epigenome editing through
the recruitment of functional domains to DNA sequences
of interest (Fig. 1). Chromatin is, however, an incredibly
complex and dynamic regulatory system, which offers
both unique opportunities and challenges for this class of
technologies. Here, we review the current state of epige-
nome engineering. Specifically, we discuss new tools and
approaches that have allowed researchers to address, in-
terrogate, and reprogram four key features of chromatin:
(1) the biochemical diversity of chromatin modifications,le is distributed under the terms of the Creative Commons Attribution 4.0
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chromatin modifications, (3) the memory and long-term
stability of modifications, and (4) the potential for long-
range spatial regulation (Fig. 1). Throughout, we highlight
key design considerations and challenges and suggest























Fig. 1 Epigenome engineering is the selective manipulation of chromatin an
provide a rich set of capabilities and challenges for engineering, including 1)
interactions, 3) the potential for long-term memory, and 4) the ability to regu
domains, which have been used extensively in genome engineering applicat
tools. Epigenetic editors are fusions of a DNA-binding module (zinc fingers (Z
more chromatin regulator (CR) modules. Each ZF domain recognizes ~3–4 nu
nucleotide. The Cas9 protein is directed to its target site by an engineered gu
pairing. dCas9 nuclease-null Cas9 protein. c The manipulation of chromatin an
eraser schemes. Molecular writers and erasers serve to catalyze the transfer an
interpreted by readers, which function to recruit and/or alter functionality. Insthese functional tools can be expanded to help to answer
fundamental questions about gene and cellular regulation
and we tackle a range of application spaces. Finally, we
note that synthetic control over chromatin provides new
capabilities in the field of synthetic biology, the engineer-























d epigenetic modifications in the genome. a Epigenetic modifications
a large biochemical diversity, 2) a preponderance of combinatorial
late genes over large spatial ranges. b Programmable DNA-binding
ions and are now being harnessed to design epigenome engineering
Fs), transcription activator-like effectors (TALEs) or CRISPR-Cas9) to one or
cleotide sequences, whereas each TALE domain recognizes a single
ide RNA (gRNA) that binds genomic sequences via Watson–Crick base
d epigenetic modifications can be understood in terms of reader/writer/
d removal of chemical marks on target histone residues. The mark is then
pired by and adapted from [9]
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higher-order transcriptional control in cells and program-
ming cellular memory states through the manipulation of
epigenetic marks. The development of engineered readers,
writers, and erasers that can effectively process the revers-
ible modifications made to chromatin will expand the syn-
thetic biology toolkit available for establishing synthetic
linkages in cellular networks, enabling a better under-
standing of the function of these networks and control of
complex cellular behaviors (Fig. 1) [9, 10].
Biochemical diversity: selecting modifications and
substrates
To explore and exploit the functional roles of DNA and
histone modifications, new tools are being developed to
selectively alter chromatin biochemistry at specific gen-
omic loci. One striking feature of chromatin is the large
biochemical diversity in the modifications and their sub-
strates [4, 11]. For example, with histone modifications,
a variety of residues displayed on histone tails act as sub-
strates for a range of post-translational modifications
(PTMs), including methylation, acetylation, phosphoryl-
ation, and ubiquitination. A leading hypothesis to explain
this biochemical diversity is that the marks (individual
and/or in combination) comprise a code that is read by
modular reader domains in order to drive specific tran-
scriptional and remodeling functions [12]. This form of
regulation has the potential for vast combinatorial power.
From the standpoint of designing epigenome editors, this
diversity requires that the biochemical specificities (both
the type of chemical modification and the target residue)
are defined carefully. The location within the genome at
which these modifications are made is another important
consideration, because different genomic loci exhibit dis-
tinct chromatin modifications depending on developmen-
tal and cell states. Thus, another key factor in the design
of editors is genome site or locus specificity.
Rapid advances in targeted epigenome editors
Cells use a system of chromatin effectors and associated
histone and DNA modifications to modulate and estab-
lish gene-expression states. A central goal has been to
try to link these modifications to specific functional
roles, such as transcriptional activation and repression
[2, 3, 13]. To date, our knowledge of chromatin-effector
functions has largely derived from the pharmacological
inhibition or genetic knockout of histone-modifying
enzymes. More recently, precise and comprehensive
genome-wide maps of chromatin modifications have
been generated, mapped to transcriptomes, and used to
provide further correlative evidence for chromatin functions
[14]. Nevertheless, these two approaches—genome-wide
perturbations and mapping analyses—neither account for
potential pleiotropic effects nor directly demonstrate causalrelationships between chromatin and functional states.
Therefore, in order to complement these studies and to
acquire causal and functional connections between chro-
matin modifications and their putative functions systemat-
ically, we need approaches that can selectively perturb
chromatin biochemistry at specific genomic loci.
The advent of programmable DNA-targeting technolo-
gies, including ZFs [15], TALEs [16–18], and the
CRISPR/Cas systems [19–21], has begun to make this
possible. These technologies have been used, with tremen-
dous success and excitement, to create programmable nu-
cleases for genome editing in a wide range of cells and
organisms [15, 16, 22–24]. The ability to target specific
DNA sequences in eukaryotic genomes is now being har-
nessed to explore whether the epigenome can be similarly
edited in a site-specific manner. The basic design of an
epigenome editor is a fusion of a DNA-targeting module
to one or more chromatin regulators (CRs; Fig. 1b).
To date, efforts have largely focused on creating
programmable writers (fusions to enzymes that catalyze
chemical modifications of DNA or histone residue(s)) and
erasers (fusions to enzymes that remove chemical modifi-
cations) (Table 1).
Early examples of epigenome editors include
programmable DNA methyltransferases [25–27] and
demethylases [28–31], histone methyltransferases and
demethylases [32–34], and histone acetyltransferases
and deacetylases [33]. In addition, the use of transcriptional
activators or repressors that have been reprogrammed to
target specific loci can initiate chromatin-mediated changes.
For example, ZF fusions to the Krüppel-associated box
(KRAB) repressor domain of the transcription factor Kox1
have been shown to suppress the expression of endogenous
target genes, such as Sox2, in breast cancer cells through
chromatin modifications [35]. The KRAB domain recruits
co-repressor KAP1 (KRAB-associated protein 1), which
in turn assembles a repressive state by nucleosome-
remodeling and deacetylation (NuRD), de-acetylation of
histones, incorporation of H3K9me3 (SETDB1), and ul-
timately heterochromatin formation [36, 37]. Other
approaches have used the chromoshadow domain of
heterochromatin protein 1 (HP1) to induce heterochro-
matin formation when targeted to a defined locus by
ZFs [38] or LacI [39]. Similarly, fusions to the p65 do-
main of the mammalian transcription factor NFkB have
been used to activate a variety of endogenous genes
(and transgenes), principally by promoting histone
acetylation via recruitment of p300/CBP [40].
Genomic specificity
Ideally, the activity of an engineered epigenome editor is
localized to a specific genomic location. One key way of
controlling this is through the DNA-targeting module. In-
deed, the targeting specificity of the DNA-binding module
Table 1 Molecular writers and erasers of chromatin modifications
Modification Substrate specificity Putative functions Example proteins/domains Epigenetic engineering applications
Target locus DBD CR fusion Reference
DNA
Methylation
Writer Cytosine Repression DNMT1, DNMT3 Human endogenous
promoter
ZF hDnmt3a CD [25]
Reporter plasmid in
mammalian cells





ZF hDNMT3a CD [27]
Eraser Cytosine Activation TET1, TET2, TDG Human endogenous
promoter





TALE, ZF TET1 FL, CD [29]
Mouse endogenous
promoter
RHD TDG FL [30]
Mouse endogenous
promoter




Writer H3 (14,18,27), H4
(5,8), H2A (5), H2B
(12,15)




p300 FL, CD [53]
Reporter plasmid in
mammalian cells
Gal4 p300 FL, CD [131]
Integrated reporter in
mammalian cells
LexA p300 HAT [132]
H3 (9,14,18) Activation, DNA repair PCAF, GCN5
H4 (5,12) Histone deposition HAT1
H4 (5,8,12,16), H3(14) Activation, DNA repair TIP60
H4 (5,8,12) HB01
Eraser H3 (9, 56), H4 (8, 16) Repressive chromatin
establishment,
metabolism
















Table 1 Molecular writers and erasers of chromatin modifications (Continued)
Methylation
Lysine (Kme)
Writer H3 (4) Activation MLL (1,2,3,4,5), SET1 (A,B),
ASH1
Reporter gene in flies Gal4 Ash1 FL, CD [134]
H3 (36) Repression, transcriptional
elongation
SET2, NSD1, SYMD2 Integrated reporter in
yeast
LexA Set2 FL, CD [135]
H3 (79) Transcriptional elongation,
euchromatin
DOT1










Gal4 G9a FL [136]
Reporter plasmid in
mammalian cells
Gal4 SUV39h1 FL, CD [137]
H3 (27) Repression EZH1/2, WHSC1
H4 (20) Repression, activation,
DNA repair, cell cycle
Pr-SET(7,8), SUV4 20H(1,2)
Eraser H3 (4) Downregulation of
proximal genes
LSD1, BHC110, jumonji class Human endogenous
enhancer
TALE LSD1 FL [32]
H3 (36) JHDM 1 (a, b), JMJD2A/
JHDM3A, JMJD2C/GASC1




Writer H3 (2, 17, 26) Activation CARM1
H4 (3) Activation PRMT4
Ubiquitylation
Lysine (Kub)
Writer H2B (123/120) Activation RNF (20, 40)
H2A (119) Repression Bmi/Ring1A
Phosphorylation
Threonine (Tph)













Table 1 Molecular writers and erasers of chromatin modifications (Continued)




H2A (139) DNA repair ATR, ATM, DNA-PK
H2B (14) Apoptosis Mst1
Proline isomerization
Proline (Pisom)
Writer H3 (30, 38) Activation/repression ScFPR4
Activation, transcriptional activation; repression, transcriptional repression. See also [34] for examples of engineered histone deacetylases (HDACs), methyltransferases (HMTs), acetyltransferase (HAT) inhibitors, and
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an editor, specifically by directing CR activity to a specific
genomic locus and thereby minimizing opportunities for
off-target effects. Studies that directly compare the activity
of an editor across the different classes of DNA-binding
modules are lacking, but different patterns of off-target ac-
tivity have been detected, for example, for KRAB fusions
to ZFs and nuclease-null dCas9 [41–43].
The genome-wide specificities of programmable DNA-
binding modules, and strategies for improving them,
have been the subject of considerable recent study [15,
44], which will not be discussed here. Epigenome editing
will certainly benefit from these strategies, which include
directed evolution [45], reducing non-specific DNA-
binding energy [46, 47], truncating guide RNAs (gRNAs)
in CRISPR systems [48], and structure-guided rational
protein engineering [49, 50].
The genomic specificity of an editor can also, in some
cases, be enhanced by altering the activity of the CR by
changing its catalytic activity or its intrinsic interactions
with binding partners, such as other regulatory proteins
or DNA [41]. For example, for ZF fusions of DNA meth-
yltransferases, mutants that had reduced catalytic activ-
ity gave rise to methylation that was more specific to
targeted sites than that in the wild type [51, 52], presum-
ably because the catalytic activity of the editors was
more dependent on DNA binding.
Biochemical specificity
The use of full-length CRs and potent transcriptional ac-
tivators or repressors, such as KRAB and p65, can be ef-
fective in inducing chromatin-mediated transcriptional
changes. However, these components are known to re-
cruit multiple chromatin-modifying activities and to in-
duce broad chromatin changes, which confound our
ability to link specific modifications to specific functional
roles. Addressing this issue requires epigenetic editors
that have precise control over the desired chromatin-
modifying activities. It also requires quantifying the
biochemical specificity of an epigenetic editor, that is,
quantifying the full array of modifications made to a
locus that has been targeted by an editor. These modifi-
cations are inherently more challenging to quantify than
genomic specificity: a comprehensive panel of DNA his-
tone modifications must be assessed using techniques
such as chromatin immunoprecipitation (ChIP) with
many different antibodies.
Strategies to create epigenetic editors that have im-
proved functional or biochemical specificity have been
explored. One key strategy is to truncate chromatin-
modifying enzymes to their catalytic core domains. A
notable recent example involved the human co-activator
protein p300, which functions as a histone acetyltransfer-
ase and mediates interactions with multiple transcriptionfactors to regulate many genes in tissues throughout the
body. By fusing the catalytic core of the p300 acetyltrans-
ferase to dCas9, Hilton et al. [53] created a programmable
histone acetyltransferase. They showed that this minimal
fusion protein was able to catalyze the acetylation of
H3K27 at target promoter sites, which led to robust tran-
scriptional activation of target genes. This elegant study
provides strong support for histone acetylation as a causal
mechanism for transcriptional activation, but it also high-
lights the challenges associated with functionally annotat-
ing specific chromatin modifications. In this particular
study, it remained unclear whether H3K27 acetylation
causes the observed transcriptional effects or whether an-
other histone lysine at the site (or perhaps even a lysine
residue on a completely different protein) causes these ef-
fects. These efforts would benefit from new and improved
methods for quantifying biochemical specificity in the
context of epigenome-editing experiments.
A related strategy for improving the functional specifi-
city of epigenetic editors is to remove non-catalytic
domains or components from CRs in order to minimize
the potential for non-specific interactions. For example,
site-specifically recruiting the minimal catalytic domain
of the histone methyltransferase SUV39H1 with a ZF
array efficiently repressed the VEGF-A promoter, whereas
full-length SUV39H1 did not cause repression [54]. Pre-
sumably this was because the intact HP1 interaction
domain present in full-length SUV39H1 functioned to
titrate the protein away from the VEGF-A gene. Related
examples include coupling of the catalytic domains
of chromatin-modifying enzymes to dCas9 [53], ZFs
[25, 40, 53–59], TALEs [33, 53, 60, 61], or use of the
Gal4 DNA-binding domain [26] to repress or silence
endogenous genes.
Collectively, these studies have used fusions to minimal
catalytic domains to develop epigenetic editors that have
improved functional specificity. Efforts to truly isolate and
re-engineer the catalytic domains of CRs will be key to im-
proving the functional specificity of epigenetic editors.
Ongoing challenges
In addition to improving biochemical and site specificities,
several important challenges remain. Current efforts have
been focused predominantly on constructing epigenome
editors by fusing writer or eraser domains with DNA-
targeting elements. Engineered readers remain largely
underdeveloped (Table 2). Potential applications of epige-
nomic readers include in vivo reporting on aberrant or
disease-related modifications. An in vivo ChIP approach
could feedback to an epigenome effector for reconfigur-
ation of a detected aberrant modification state. In one ex-
ample, a synthetic transcription factor was engineered by
fusing the VP64 activation domain to the Polycomb chro-
modomain (PCD) [62]. The PCD of this synthetic
Park et al. Genome Biology  (2016) 17:183 Page 8 of 17transcription factor recognizes H3K27me3 that is associ-
ated with silenced genes and reactivates these genes. En-
gineering readers remains challenging for two reasons.
First, it may be difficult to engineer a single histone reader
domain that is specific for a particular histone residue.
Combining multiple different reader domains, which is a
common mode of natural chromatin regulation, may solve
this problem. Second, as all similarly modified nucleo-
somes will look alike to chromatin readers, the readers
will bind modifications throughout the genome rather
than at specific locations. A combination of DNA- and
chromatin-binding modalities may provide a solution.
Given the complexity of chromatin biochemistry, there
are probably many other features that will be important
for the design of future epigenome-modifying tools. For
example, histone lysine residues can exist in mono-, di-,
and trimethylated states. Being able to finely tune thisTable 2 Molecular readers of chromatin modifications





















Double tudor domain H3K4me
Hybrid tudor domains (HTDs) H3K4me
Chromodomain Y-chromosome (CDY) [74] H3K9me
Multivalent binding
Bromo + Bromo H4K5ac
PHD + Bromo H3K4me
H3K9ac/
Tudor + Bromo H3K9ac/
Other useful references and guides [4, 140–142]feature of chromatin modification could reveal its func-
tional role and potentially provide fine-tuned control of
transcriptional activity.
Continued work on characterizing and discovering
new catalytic domains will expand the list of available
parts from which to select for improved properties such
as substrate specificity [63–71]. Another interesting ap-
proach for improving the catalytic activity of epigenome
editors is to fuse the catalytic core domains of multiple
subunits or co-recruiting synergistic co-factors. For ex-
ample, fusion of the catalytic C-terminal domains of
DNA methyltransferase 3a (DNMT3a) and DNMT3L in-
duced DNA methylation at the VEGF-A promoter with
better efficiency than did the DNMT3a catalytic domain
alone, by mimicking a stable Dnmt3a–Dnmt3L heterodi-
mer [59]. DNMT3L, despite its lack of catalytic activity,















h, H3S28p 14-3-3 ζ
2, H3K9me2, H4K20me2 53BP1
2/3, H4K20me2/3 JMJD2A
3, H3K27me3
+ H4K12ac TAF1 (subunit of TFIID)
3 + H4K16ac BPTF
H3K12ac + H3K4me3 TFIID
H3K14ac + H3K4me3 SAGA complex
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tion by coupling multiple subdomains that have cata-
lytic or structural functions may be a better reflection
of the natural mode of chromatin regulation.
Combination and context
There exist a surprisingly large number of epigenome
modifications. The combinatorial interactions between
these modifications and other chromatin-bound proteins
increase this complexity even further. In fact, most chro-
matin states that are associated with regions such as
active promoters and enhancers are characterized by
specific combinations of chromatin modifications [72].
Why did this combinatorial complexity evolve? One rea-
son could be that single modifications alone are not suf-
ficient to account for all the distinct states that need to
be specified or marked. Perhaps a more intriguing possi-
bility is that combinatorial interactions set the stage for
context-dependent regulation and enhance locus-specific
recruitment.
With context dependency, one modification could
mask, modulate, or enhance the binding interaction of a
reader of a second modification. This is seen in the asso-
ciation of HP1 with H3K9me3, which is abolished by the
dynamic and transient phosphorylation of the adjacent
Ser10 residue [73]. Similarly, association of the double
chromodomains of CHD1 with H3K4me3 is reduced by
demethylation of Arg2 (a two-fold reduction) or by
phosphorylation of Thr3 (a 25-fold reduction). Trans-
histone crosstalk can also occur, as found in COMPASS
(Complex of Proteins Associated with Set1), the yeast
homolog of the mammalian MLL complex [74]. A global
functional proteomic screen revealed that monoubiquiti-
nation of histone H2B by Rad6 is required for H3K4
methylation by COMPASS and for H3K79 methylation
by Dot1 [75]. The recruitment of Cps35, an essential
subunit of COMPASS, to chromatin in the presence of
H2B monoubiquitination facilitates the recruitment of
COMPASS and Dot1. Thus, combinatorial modifications
may act as gates, allowing events to occur only in a par-
ticular order.
Combinatorial modifications could also prime a gene to
follow one of multiple possible paths. Certain domains of
the embryonic stem (ES) cell genome possess both activat-
ing and repressive histone modifications, known as
bivalent domains; these are typically enriched at develop-
mentally important genes [76, 77]. It is proposed that
genes that have bivalent domains are poised for either ac-
tivation or repression, depending on the differentiation
path that the cell ultimately follows.
Gene expression is precisely controlled in time and
space by the integration of this diverse array of PTM sig-
nals and the actions of multiple chromatin-regulating
factors operating in multifactorial ways [3, 78]. If we candesign epigenome editors to control these complex
states, we may be able to fully unveil the context de-
pendency of chromatin regulation and thus understand
whether the pre-established chromatin context will
affect (cancel out, enhance, or synergize) the effective-
ness of the following chromatin regulation. We might
then be able to adopt the true combinatorial features
of natural chromatin communication in a range of
applications.Combinatorial and high-throughput techniques reveal
contextual and combinatorial principles
The interactions between chromatin proteins, chromatin
modifications, and the surrounding DNA sequence and
chromatin state determine local transcriptional outputs.
This is key for the design of functional epigenome edi-
tors because behaviors that are observed at one specific
locus may not hold at another locus where the presence
of existing proteins may alter the activity of a recruited
epigenome editor. Therefore, one important goal for epi-
genome engineers is to reveal the rules of chromatin
context. Accessing and deciphering these rules will re-
quire high-throughput and combinatorial techniques.
There have been several in vitro methods for the rapid
assessment of combinatorial and contextual properties
of epigenome editors [79], but the intracellular and
intranuclear environments are likely to have significant
effects. To overcome the technical hurdles of working in
the cellular environment, library-based methods can
functionally assay comprehensive sets of regulators
in vivo. For example, Akhtar and colleagues [80] ran-
domly integrated thousands of barcoded reporter
transgenes into the genome using piggyback transpos-
ition (Fig. 2a). By assaying cells with integrated re-
porters (IRs), these authors could test whether the local
chromatin compaction state prior to integration had
predictive power for IR expression levels. Analysis of
normalized transgene expression by high-throughput
sequencing of the library revealed non-random patterns
of IR expression, which was strongly dependent on
local chromatin context.
In our group, Keung et al. [81] fused a comprehensive
set of 223 yeast CRs to programmable ZF proteins
(Fig. 2b). We site-specifically co-recruited the CRs to-
gether with the commonly used transcriptional acti-
vator VP16 to diverse arrays of synthetic reporters.
This revealed a range of transcriptional logic and be-
haviors, demonstrating the complexity of chromatin
regulation. We divided this range of logic into six
distinct classes of combinatorial regulation: dominant
repressors, repressors, neutral factors, enhancers of
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Fig. 2 Interrogating the contextual and combinatorial principles of epigenome regulation. a A method for the parallel monitoring of the transcriptional
activities of thousands of randomly integrated, barcoded reporters was used to study chromatin position effects across the genome. b Synthetic
chromatin regulators (synCRs), composed of fusions of programmable zinc fingers (ZFs) and subunit proteins derived from diverse chromatin-regulating
complexes, were used to study and program transcriptional outputs produced by individual and combinations of CRs at integrated reporters. GFP green
fluorescent protein. c CRISPR/dCas9 can be exploited for high-throughput functional assays of epigenetic regulators thanks to its experimental tractability
for combinatorial and multiplexed recruitment. Scaffolding multiple RNA-hairpin motifs to a guide RNA (gRNA) allows multivalent recruitment
of chromatin regulators (CRs). Scaffolding different RNA motifs to gRNA allows heterologous recruitment of CRs. The same CR can be
simultaneously recruited to multiple loci by using different gRNAs specific to each gRNA locus
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The simplicity of programming the CRISPR-Cas9 system
to target multiple endogenous genomic loci simultan-
eously [82–84] and/or to recruit multiple different protein
domains [85] to a locus offers a powerful platform with
which to decipher the combinatorial and contextual com-
plexity of the epigenome (Fig. 2c). The experimental tract-
ability of CRISPR/Cas9 genome editing tools for high-
throughput approaches exceeds that of any other currently
available DNA-targeting platform [86–90]. Creatively le-
veraging previous systems could also expand theparameter space that is explored. For example, the plat-
form that Akhtar and colleagues [80] developed could be
adapted to study additional contextual effects. With only
minor modifications in the experimental design, DNA se-
quence elements could be added or other chromatin mod-
ifiers recruited in front of the reporter gene to ask how
each component interacts with each endogenous state.
Memory and epigenetics
Among the myriad modifications being written and
erased on chromatin, a subset is stably inherited through
Park et al. Genome Biology  (2016) 17:183 Page 11 of 17mitotic or meiotic cell divisions. These epigenetically
inherited modifications are important for the mainten-
ance of gene expression patterns throughout the differ-
entiation and developmental processes of mammals and
may result in disease or cancer when mis-regulated
[8, 91]. Several important examples of behavioral and
disease traits are inherited across generations in com-
plex organisms, including mice [92]; here we focus on
cellular studies because studies of the mechanistic
roles of epigenome modifications are more feasible.
Understanding and controlling epigenetic modifica-
tions could also have an impact on biotechnology and
synthetic biology, where stable biological switches are
highly desired.
A variety of different mechanisms underlie epigenetic
properties but they all depend on some form of feed-
back. Broadly, feedback mechanisms can be trans- or
cis-acting or a combination of both [93]. Trans-acting
mechanisms typically involve positive feedback of a tran-
scription factor in the regulation of its own gene. This
mechanism is utilized both to establish and to self-sustain
a specific transcriptional state of a gene, as demonstrated
in the activation and maintenance of differentiated func-
tions of nematode sensory neurons [94, 95] and widely in
maintaining differentiated cell identity [96, 97]. Cis-acting
mechanisms more often involve chromatin modifications
directly. DNA methylation in mammals is a prime ex-
ample [98]. DNA methylation is crucial in the establish-
ment of epigenetic memory that is essential for normal
development [99, 100]. Work in vertebrates has been fo-
cused mostly on the methylation of cytosine in the context
of CpG di-nucleotides at transcription start sites (TSSs),
which is believed to maintain genes in a locked-in off
state. Recent advances in the genome-scale mapping of
methylation has found additional context-dependent func-
tions (in, for example, TSSs, gene bodies, and enhancers)
that go beyond the repressive association of DNA methy-
lation [101]. Epigenetic memory by DNA methylation is
established through the DNA-strand to DNA-strand copy-
ing action of DNMT1 and through the recruitment of re-
pressive regulatory proteins upon de novo methylation by
DNMT3 [98]. However, this classic model for epigenetic
memory, with the canonical distinction between the roles
of DNMT3 and DNMT1, is being challenged by recent
experimental evidence [102, 103].
Histone modifications are also involved in maintaining
epigenetic regulation. For example, antagonizing groups
of protein complexes, the Polycomb (PcG) and trithorax
(trxG) groups, mediate the mitotic inheritance of repres-
sive and active transcriptional states, respectively [104].
There is also evidence that some heterochromatic his-
tone modifications crosstalk with and may derive their
stability from DNA methylation [105, 106]. These exam-
ples point to the important role of chromatin in stablymaintaining the transcriptional state of critical lineage-
specifying genes. The exact mechanisms that underlie
these epigenetic properties of chromatin modifications
have been difficult to pin down given the time-dependent
nature of gene-expression memory. Nevertheless, several
temporally dynamic experimental approaches using epige-
nome editors have and will continue to shed light on the
molecular feedback underlying memory in chromatin
systems.
Synthetic systems can directly induce epigenetic
chromatin states
In a landmark study, Hathaway et al. [38] developed a
chemically inducible system to establish and erase hetero-
chromatin in vivo at the Oct4 locus (Fig. 3a). The chro-
moshadow domain of HP1α was site-specifically directed
to ZFHD1-binding sites via FKBP-Frb dimerization do-
mains in the presence of rapamycin. Upon transient re-
cruitment of HP1α, a >10-kb region of H3K9 methylation
was established and maintained through multiple cell divi-
sions (over at least several weeks), even after the release of
HP1α. By measuring the kinetics and stability of chroma-
tin modification establishment and turnover, Hathaway
et al. [38] generated a computational model that incorpo-
rated a feedback mechanism between DNA methylation
and H3K9 methylation.
The relationship between DNA methylation and H3K9
methylation, as well as other types of repressive modifi-
cations, was further investigated by Bintu et al. [107] in
an elegant synthetic biology study. These authors devel-
oped a framework to quantitatively interrogate the kinet-
ics and stability of gene repression induced by four
proteins that act through different types of chromatin
modifications: (1) embryonic ectoderm development
(EED) of Polycomb Repressive Complex 2 (PRC2)
(H3K27 methylation), (2) KRAB (H3K9 methylation), (3)
DNMT3B (DNA methylation), and (4) histone deacety-
lase 4 (HDAC4) (histone deacetylation) (Fig. 3b). Each
protein was transiently recruited for different periods of
time to a fluorescent reporter gene using the reverse
Tet repressor (rTetR). Using single-cell time-lapse mi-
croscopy, Bintu et al. [107] observed that the reporter
turned on and off in an all-or-none fashion for all of
the chromatin modifiers studied. Yet the time it took
for the reporter to turn off and the stability of re-
pressed reporter differed depending on the modifier.
In fact, each type of chromatin modification led to
different kinetics and stabilities of gene repression,
suggesting that the epigenome may encode different
operational types of gene regulation.
The strong epigenetic properties of DNA methylation
were confirmed in both studies. Nevertheless, studies
are still attempting to confirm whether various histone
modifications are truly epigenetic, that is, self-sustaining
















































Fig. 3 Use of epigenome editing tools to study the dynamics and memory of epigenetic regulation. a The selective recruitment of HP1α to specific
loci in live cells was used to establish H3K9me3-dependent gene silencing and to study the kinetics and extent of heterochromatin. b In another study,
doxycyline (DOX) was used to selectively recruit four repressive CRs that are associated with diverse chromatin modifications (Krüppel-associated box
(KRAB) (associated with H3K9 methylation), embryonic ectoderm development (EED) (associated with H3K27 methylation), DNA methyltransferase 3B
(DNMT3B) (associated with DNA methylation), and histone deacetylase 4 (HDAC4) (associated with histone deacetylation)). By tracking transcriptional
output of a reporter gene in individual cells, researchers discovered that cells stochastically transition between active and silent states. These dynamics
were described by a simple three-state model, in which different CRs operate over different time scales to modulate the fraction of cells in a
population that are in each state. YFP yellow fluorescent protein
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cessary DNA sequence [95, 108, 109]. For example, the
artificial recruitment of the PRC2 complex via a
tetracycline-inducible GAL4–EED fusion protein in-
duced H3K27me3, and this modification was maintained
even after repression of GAL4–EED [110]. More re-
cently, two studies have provided compelling evidence
for the epigenetic inheritance of H3K9 methylation in
the fission yeast Schizosaccharomyces pombe [111, 112].
A particularly important aspect of these findings was
that the epigenetic inheritance of H3K9 methylation was
decoupled from any DNA sequence and could be estab-
lished at genomic loci that are normally devoid of H3K9
methylation and heterochromatin. In these two studies,the H3K9 methyltransferase Clr4 was recruited to the
ade6+ gene [111, 112]. Transient recruitment of Clr4
was controlled by tetracycline-dependent release of
TetR–Clr4. Interestingly, while the establishment of high
levels of H3K9 methylation was subsequently lost upon
release of the TetR-Clr4 initiator (within around ten cell
divisions), deletion of the putative demethylase Epe1 re-
sulted in H3K9-methylation-mediated silencing at the
tethering site through many mitotic and meiotic divi-
sions. These results suggest that the inheritance of
H3K9 methylation is determined by the balance of a
feedback loop between methylation by Clr4 through a
reader–writer mechanism and active demethylation by
Epe1. These studies demonstrate the synergy of forward-
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of the genomic locus and of the timing of Clr4 recruit-
ment) and chromatin biology techniques and genetics in
demonstrating the factors required in the epigenetic
maintenance of H3K9 methylation.
Future work
Many other histone modifications still remain to be
tested for their epigenetic properties and many molecu-
lar details of epigenetic mechanisms remain to be dis-
covered [27]. These ongoing studies may benefit from
technical advances that will make it possible to dynamic-
ally recruit proteins and to interrogate large parameter
spaces in high-throughput screens for minimal factors
that are required for epigenetic maintenance. For ex-
ample, to identify the minimal factors required for epi-
genetic chromatin states, CRISPR-Cas9 systems could be
used either to knockout chromatin proteins and/or to
recruit multiple factors to specific genomic loci [38,
111–113]. In addition, greater temporal control could
provide more precise information on the stability and
kinetics of epigenetic systems. This could be achieved
through the use of light-activated protein systems.
Konermann et al. [33] demonstrated that 32 repressive
histone effector domains could be conditionally targeted
to a genomic locus via the light sensitive cryptochrome
2 (CRY2) protein and its interacting partner CIB1 from
Arabidopsis thaliana [33]. This particular study was not
focused on identifying the epigenetic properties of the
chromatin modifiers, but this technique holds potential
as a toolkit that can provide high temporal resolution
with which to study epigenetic mechanisms and identify
epigenetic factors [114].
Many opportunities for exploiting the unique features
of epigenetic regulation lie ahead. Researchers could
work to harness any potential restricted or conditional
epigenetic inheritance of histone modifications for devel-
oping “short-term” or “flexible” epigenetic memory cir-
cuitry [99], which could be intentionally designed to
maintain the edited epigenome state for a short period
of time. For example, there may be instances, in normal
development or for transient therapeutic applications,
that require that genes are regulated such that they are
suppressed for a short period of time and subsequently
reactivated. The repressive state of a gene could be in-
duced with repressive histone methyltransferases and
later (before one cell cycle is completed or within very
few cell divisions) reversed by either demethylases or a
passive histone dilution mechanism. By contrast, complete
and permanent repression of genes could be achieved with
the incorporation of DNA-methylation-mediated gene
silencing [25, 56]. It is important to note that there is
evidence to suggest that transiently induced DNA
methylation is not maintained, highlighting theimportance of multivalent deposition of functionally
related epigenetic marks for truly stable reprogram-
ming [57]. Either short-term or long-term epigenetic
memory could be a valuable feature of many applica-
tions, including gene and cell therapy. Finally, while
the epigenetic maintenance of chromatin and gene
expression states has been demonstrated in several
cellular systems, exciting but challenging work lies
ahead in using epigenome editing tools to study the
long-term heritability of chromatin modifications
(such as DNA methylation [92, 98]) across genera-
tions of complex organisms such as mice.
Artificial perturbations of chromatin structure
Chromatin adds a unique spatial element to gene regula-
tion at multiple scales [115, 116]. For example, certain
histone modifications have been observed to demarcate
and preserve chromatin domains such as silent hetero-
chromatic and active euchromatic regions. These regions
are hypothesized to be established and preserved by
highly dynamic processes involving histone modifica-
tions; these include self-reinforcing mechanisms that
spread modifications along adjacent nucleosomes [111,
112], so-called “reader-writer” mechanisms [117]. Chro-
matin’s three-dimensional conformation and positioning
in the nucleus also orchestrate gene expression. For ex-
ample, looping mediates long-range genomic interac-
tions by juxtaposing distal regulatory elements such as
enhancers with distant loci, to either coordinate their ex-
pression or co-localize regulatory factors. This type of
spatial organization is observed in tissue-specific gene
regulation, in which genomic elements cluster together
at certain stages of development [118]. Tools that can
replicate or perturb chromatin’s spatial properties will
enhance our ability to study and potentially harness
these complex mechanisms.
Several molecular approaches have already been used
successfully to perturb chromatin structure and these
studies suggest that continued work in this area could
reveal important and potentially useful regulatory princi-
ples relating to chromatin shape. For example, an ectopic
repressor assay using a drug-inducible ZF-KRAB fusion
protein demonstrated that KRAB-mediated repression
spans tens of kilobases and is established by the long-
range propagation of H3K9me3 and HP1 β [119]. This
and similar approaches [38, 81] provide us with the
unique ability to regulate multiple genes in tandem using
a single regulator. Furthermore, transcriptional activators
and repressors that are recruited site-specifically to re-
gions more than 1 kb downstream of promoters can acti-
vate [120] and repress [121] yeast genes, respectively,
when they are placed near telomeres. This effect “at a dis-
tance” is mediated by a telomere-position effect in yeast,
which is analogous to the position effect variegation
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euchromatic gene is juxtaposed with heterochromatin by
structural rearrangement and becomes silenced [122].
Modeling efforts along with site-specific recruitment ap-
proaches have also provided insights into how multiple
regulators that have opposing functions (active or repres-
sive) are coordinated to regulate genes in a way that is de-
termined by the spatial distribution of nucleation sites
along the chromosome [123, 124]. These studies can help
to explain the expression pattern of adjacent genes in a
certain positioning context and could potentially unveil
the mechanisms of variegated gene expression.
Recent efforts have begun to directly manipulate chro-
matin looping and to change the three-dimensional con-
tact profile of genes with other loci or nuclear structures
(Fig. 1). Deng and colleagues [125, 126] employed ZFs to
override a stringent developmental gene expression pat-
tern by artificially forcing chromatin looping. Specific-
ally, these researchers forced chromatin looping between
the β-globin gene and its distal regulatory region, the
locus control region (LCR) which is positioned 40 kb
away. This looping was induced by synthetically tether-
ing Ldb1, a protein present at the LCR, to the β-globin
promoter, which led to Ldb1–Ldb1-mediated chromatin
looping. Deng and colleagues demonstrated that forced
chromatin looping was sufficient for activation of the β-
globin gene [125, 126]. They then showed that forced
chromatin looping that was achieved by tethering Ldb1
to a developmentally silenced embryonic globin gene
was sufficient to trigger the gene’s reactivation. These
studies demonstrate a novel approach to control the
three-dimensional structure of the epigenome.
There are other ways to induce structural perturba-
tions in chromatin. Even a change in the direction of a
small fragment (~20 bp) of DNA sequence can control
transcriptional activity by reconfiguring the topology of
chromatin loops [127]. CCCTC-binding factor (CTCF)
insulators and the associated cohesion complex play im-
portant roles in higher-order chromatin organization in
mammalian genomes. By reversing the relative orienta-
tion of CTCF-binding sites by CRISPR/Cas9-based gen-
ome editing, changes in the directionality of DNA
looping and gene expression can be made [127]. Such ef-
forts will be key to elucidating the relationship between
DNA sequence elements and the three-dimensional
structure of chromatin.
Structural- or spatial-factor-dependent regulation of
gene expression can also be mediated by spatially posi-
tioning genes in the nucleus. The randomly integrated
reporter platform of Akhtar and colleagues [80], for
example, revealed spatial positioning effects that corre-
lated with gene expression. Lamina-associated domains
(LADs), late-replicating domains, and regions marked by
the histone modification H3K9me2 often coincide withone another and harbor mostly inactive endogenous
genes [128]. In addition, the integrated reporters, much
of whose fold change was unaccounted for by local chro-
matin compaction, were more actively expressed when
integrated near active genes. Akhtar and colleagues pro-
posed that these effects are a result of the collective ac-
tions of enhancers and transcription units in creating
transcription-promoting regions, again highlighting the
functional importance of how genes are spaced along a
chromosome.
Concluding remarks
In this review, we have discussed important features that
must be considered when designing functional epige-
nome engineering tools and current challenges that need
to be addressed. The impact of recent advances in epige-
nome engineering has been remarkable in terms of both
understanding the underlying mechanisms of epigenome
regulation and designing new ways to regulate genes for
future biomedical and biotechnological applications.
Forward-engineering approaches allow researchers to
directly interrogate the relationships between the epige-
nome and transcriptional function. These approaches
are highly complementary to other cell biology methods
and are particularly useful for systematically exploring
large parameter spaces [9]. In addition, epigenome editing
technologies hold considerable promise for engineering
applications. The application of engineering principles to-
ward the construction of novel biological systems (i.e.,
synthetic biology) could take advantage of this additional
class of chromatin-based regulation. The many features of
epigenome regulation present interesting properties or
functional connections that could be exploited in assem-
bling synthetic biological networks [10]. Ultimately, epige-
nome editing may emerge in new forms of gene therapy
by modifying/correcting diseased epigenome states with-
out making permanent and potentially deleterious genetic
changes in cells [8, 26, 129].
Perhaps one of the most exciting prospects in develop-
ing new epigenome editing tools is how they may alter
our perspective of the function and nature of the epigen-
ome’s complexity. Several current models depict chro-
matin modifications as an additional layer of regulatory
nodes that act in concert with genetic networks to co-
ordinate cellular programs [130]. With our increasing
ability to interface, perturb, and establish these regula-
tory nodes, we can begin to think of the epigenome as a
powerful set of operations that can be performed on sig-
nals from and between various levels of cellular regula-
tion. Given the widespread use of the epigenome in
nature, there is good reason to believe that epigenome
editing, and the predictable manipulation of chromatin
modifications, will serve as a powerful new paradigm for
synthetic biology and bioengineering. No longer will the
Park et al. Genome Biology  (2016) 17:183 Page 15 of 17epigenome be a complex problem to decipher, but rather
a powerful platform to harness.
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